334 related articles for article (PubMed ID: 15165825)
1. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
2. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
3. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
[TBL] [Abstract][Full Text] [Related]
4. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
Martarano L; Stephens R; Rice N; Derse D
J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
[TBL] [Abstract][Full Text] [Related]
5. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
Gontarek RR; Derse D
Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
[TBL] [Abstract][Full Text] [Related]
6. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
7. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
[TBL] [Abstract][Full Text] [Related]
8. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
Derse D; Dorn P; DaSilva L; Martarano L
Dev Biol Stand; 1990; 72():39-48. PubMed ID: 2178129
[TBL] [Abstract][Full Text] [Related]
9. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
[TBL] [Abstract][Full Text] [Related]
10. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
11. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
Derse D; Newbold SH
Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
[TBL] [Abstract][Full Text] [Related]
13. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
Maury WJ; Carpenter S; Graves K; Chesebro B
Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
[TBL] [Abstract][Full Text] [Related]
14. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
Ashiya M; Grabowski PJ
RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
[TBL] [Abstract][Full Text] [Related]
15. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
Jumaa H; Nielsen PJ
EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of the NS2-specific exon in minute virus of mice mRNA is facilitated by an intronic splicing enhancer that affects definition of the downstream small intron.
Haut DD; Pintel DJ
Virology; 1999 May; 258(1):84-94. PubMed ID: 10329570
[TBL] [Abstract][Full Text] [Related]
18. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
Caputi M; Freund M; Kammler S; Asang C; Schaal H
J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
[TBL] [Abstract][Full Text] [Related]
19. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
Bilodeau PS; Domsic JK; Stoltzfus CM
J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
[TBL] [Abstract][Full Text] [Related]
20. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
Jacquenet S; Decimo D; Muriaux D; Darlix JL
Retrovirology; 2005 May; 2():33. PubMed ID: 15907217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
